Cargando…

2819. Clinical Outcomes of Fosfomycin Treatment in E. coli vs. Non-E. coli Enterobacterales Urinary Tract Infection

BACKGROUND: Oral fosfomycin tromethamine is considered a first-line agent for the treatment of uncomplicated acute cystitis in women according to the national Infectious Disease Society of America (IDSA) guideline. However, non-E. coli Enterobacterales urinary tract infection (UTI) pathogens exhibit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Traugott, Kristi, Lee, Grace, Groff, Lindsey, Aguilar, Samantha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678636/ http://dx.doi.org/10.1093/ofid/ofad500.2430

Ejemplares similares

1525. Evaluation of Clinical Outcomes With Fosfomycin for E. coli and Non-E. coli Enterobacteriaceae Urinary Tract Infections
por: Lee, Tiffany, et al.
Publicado: (2018)

611. Fosfomycin Resistance of Multidrug-Resistant Escherichia coli and Mechanisms of Fosfomycin Resistance
por: Seok, Hyeri, et al.
Publicado: (2019)

Pharmacokinetics of fosfomycin in patients with prophylactic treatment for recurrent Escherichia coli urinary tract infection
por: Kuiper, Sander G, et al.
Publicado: (2020)

Efficacy and Safety of Oral Fosfomycin-Trometamol in Male Urinary Tract Infections with Multidrug-Resistant Enterobacterales
por: Bouiller, Kévin, et al.
Publicado: (2022)

Bacillus Coli Infections of the Urinary Tract
Publicado: (1912)

342. Multicenter Evaluation of Fosfomycin MIC Results for Enterobacterales Using EUCAST V11 Breakpoints (i.v. and oral for uncomplicated UTI only, E. coli) on MicroScan Dried Gram Negative MIC Panels
por: Garner, Omai, et al.
Publicado: (2022)

High incidence of fosfomycin-resistant uropathogenic E. coli among children
por: Abdelraheem, Wedad M., et al.
Publicado: (2023)

Metabolic Adaptations of Uropathogenic E. coli in the Urinary Tract
por: Mann, Riti, et al.
Publicado: (2017)

1689. Oral Beta-lactam Step Down in Bacteremic E. coli Urinary Tract Infections
por: Saad, Stephan, et al.
Publicado: (2020)

1153. ESBL Producing E. coli Urinary Tract Infections in Children: Is Carbapenem Always Necessary?
por: del Carmen, Ruiz Cabrales Diva, et al.
Publicado: (2021)

Susceptibility of Escherichia coli from Community-Acquired Urinary Tract Infection to Fosfomycin, Nitrofurantoin, and Temocillin in Korea
por: Seo, Mi-Ran, et al.
Publicado: (2014)

2180. Novel Method for Determining Rapid E.coli Antibiotic Susceptibility (AST) Results for Urinary Tract Infections
por: Kon, Shelley, et al.
Publicado: (2019)

Antibiotic resistance in children with E coli urinary tract infection
por: Russell, Grant
Publicado: (2016)

Lactose vs Non-Lactose Fermenting E. coli: Epidemiology, Clinical Outcomes, and Resistance
por: Yaratha, Gokul, et al.
Publicado: (2017)

Molecular Epidemiology of Fosfomycin Resistant E. coli from a Pigeon Farm in China
por: Han, Lu, et al.
Publicado: (2021)

150. Urinary Tract-Associated Gram-Negative Bacteremia: Impact of Treatment Duration
por: Badwal, Jasmin K, et al.
Publicado: (2019)

2422. Efficacy of Cefoxitin for the Treatment of Urinary Tract Infection (UTI) Due to ESBL-Producing E. coli and K. pneumoniae Isolates
por: Senard, Olivia, et al.
Publicado: (2018)

Fosfomycin resistance mechanisms in Enterobacterales: an increasing threat
por: Mattioni Marchetti, Vittoria, et al.
Publicado: (2023)

Antimicrobial Susceptibilities of Urinary Extended-spectrum β-lactamase Escherichia coli to Fosfomycin
por: Saeed, Nermin Kamal, et al.
Publicado: (2021)

1526. Oral Fosfomycin Use for Urinary Tract Infections and Its Clinical Impact on Hospital Stay
por: Mai, Christina, et al.
Publicado: (2018)

Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary Tract Infections: A Randomized Clinical Trial
por: Sojo-Dorado, Jesús, et al.
Publicado: (2022)

182. increasing Odds of Resistance for Subsequent Urinary e. Coli Isolates
por: Frisbie, Lauren, et al.
Publicado: (2020)

Clinical exome sequencing: results from 2819 samples reflecting 1000 families
por: Trujillano, Daniel, et al.
Publicado: (2017)

Oral fosfomycin versus ciprofloxacin in women with E.coli febrile urinary tract infection, a double-blind placebo-controlled randomized controlled non-inferiority trial (FORECAST)
por: ten Doesschate, Thijs, et al.
Publicado: (2018)

2959. Urinary tract colonizing abilities of fosfomycin (FOF) non-susceptible Klebsiella pneumoniae (KP) inner colonies (IC) arising from disk diffusion (DD) in an ascending mouse urinary tract infection (UTI) model
por: Bixby, Morgan, et al.
Publicado: (2023)

Fosfomycin Resistance in Escherichia coli, Pennsylvania, USA
por: Alrowais, Hind, et al.
Publicado: (2015)

Characterization of E. coli Phylogroups Causing Catheter-Associated Urinary Tract Infection
por: El-Mahdy, Rasha, et al.
Publicado: (2021)

1518. Assessment of Antibiotic Prescribing in the Outpatient Setting for Uncomplicated Urinary Tract Infection in Pediatrics (UTIP Trial) with a Review of Local E. coli Susceptibilities
por: Lee, Philip, et al.
Publicado: (2018)

Fosfomycin Vs Ciprofloxacin as Oral Step-Down Treatment for Escherichia coli Febrile Urinary Tract Infections in Women: A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial( )
por: ten Doesschate, Thijs, et al.
Publicado: (2021)

Oral and intravenous fosfomycin in complicated urinary tract infections
por: López-Montesinos, Inmaculada, et al.
Publicado: (2019)

1700. What Is Specific With Bacterial Escherichia Coli Urinary Tract Infection
por: Hammami, Fatma, et al.
Publicado: (2020)

1417. Fosfomycin Use in the Treatment of Complicated Urinary Tract Infections at a Veterans Affairs Medical Center
por: Lee, Ryan, et al.
Publicado: (2021)

Detection of ESBL in E.coli and K. pneumoniae isolated from urinary tract infection
por: Metri, B. C., et al.
Publicado: (2012)

Oral beta-lactam step down in bacteremic E. coli urinary tract infections
por: Saad, Stephan, et al.
Publicado: (2020)

Disseminated E. coli urinary tract infection resulting in septic arthritis of the glenohumeral joint
por: James, Rhodri, et al.
Publicado: (2023)

Inhibition of COX-2 signaling favors E. coli during urinary tract infection
por: Mohanty, Soumitra, et al.
Publicado: (2023)

2420. A Real-World Perspective on the Efficacy of Fosfomycin for Treatment of Multidrug-Resistant Pathogens Causing Urinary Tract Infections
por: Babiker, Ahmed, et al.
Publicado: (2018)

2261. Oral Fosfomycin for Treatment of Urinary Tract Infections Due to Extended-Spectrum β-Lactamase and Carbapenem-Resistant Enterobacteriaceae
por: Hefler, Jade L, et al.
Publicado: (2019)

Effect of Glycerol on Fosfomycin Activity against Escherichia coli
por: Ortiz-Padilla, Miriam, et al.
Publicado: (2022)

Emergence of Fosfomycin Resistance by Plasmid-Mediated fos Genes in Uropathogenic ESBL-Producing E. coli Isolates in Mexico
por: Galindo-Méndez, Mario, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_259aikaouphpv0prcurb4jn431